Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
763.98 | -48,33% | -27,12% | 687.891,71 | 0,69% | 2,63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
910.00 | -1,79% | 18,59% | 4.053.901,21 | 1,03% | 18,5% |
|
NYSE:TMO
Thermo Fisher Scientific
|
594.80 | -17,36% | -8,09% | 227.044,87 | 0,26% | 14,15% |
|
SWX:ROG
Roche Holding
|
224.60 | 32,32% | 48,46% | 181.258,38 | 4,21% | 0,43% |
|
NYSE:DHR
Danaher
|
259.26 | -18,55% | -7,74% | 192.030,39 | 0,42% | 10,89% |
|
NYSE:ABT
Abbott Laboratories
|
104.01 | 2,51% | 15,26% | 180.939,31 | 2,1% | 9,04% |
|
ENXTPA:SAN
Sanofi
|
91.69 | 16,05% | 34,5% | 114.488,32 | 4,06% | 8,19% |
|
NasdaqGS:LRCX
Lam Research
|
912.54 | -44,36% | -29,18% | 119.306,39 | 0,89% | 13,8% |
|
LSE:GSK
GSK
|
18.10 | 5,36% | 20,88% | 73.812,48 | 3,2% | 0,79% |
|
ASX:CSL
CSL
|
279.58 | 22,78% | 43,75% | 135.107,8 | 1,28% | 7,18% |
|
NYSE:BDX
Becton Dickinson and Co
|
235.00 | 16,09% | 30,31% | 67.916,52 | 1,6% | 2,09% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4205.00 | 0% | 0% | 6.597.366,84 | 4,78% | 0% |
|
NasdaqGS:BIIB
Biogen
|
226.88 | -13,85% | 1,44% | 33.033,02 | 0% | -10,89% |
|
XTRA:BAYN
Bayer
|
29.22 | 63,87% | 79,86% | 28.706,43 | 0,37% | 1,47% |
|
NYSE:CAH
Cardinal Health Inc
|
97.43 | -24,42% | -13,96% | 23.730,73 | 2,04% | 2,98% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
17.09 | -48,73% | -45,42% | 19.356,83 | 0% | -2,6% |
|
NYSE:BAX
Baxter International Inc
|
35.24 | 82,83% | 110,41% | 17.957,61 | 3,27% | -3,14% |
|
NasdaqGS:HOLX
Hologic
|
75.65 | -20,95% | -14,29% | 17.654,97 | 0% | 12,17% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
79.65 | 142,2% | 221,62% | 15.385,96 | 0% | 32,46% |
|
NYSE:DGX
Quest Diagnostics
|
139.16 | -6,93% | 2,11% | 15.377,3 | 2,13% | 6,66% |
